Arcadia Biosciences, Inc. — Director's Dealing 2015

Oct 8, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2015-10-06

Reporting Person: Rey Eric J. (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-06	Common Stock	M	12614	$0.44	Acquired	122774	Direct
2015-10-06	Common Stock	S	4100	$3.2803	Disposed	118674	Direct
2015-10-07	Common Stock	M	10764	$0.44	Acquired	129438	Direct
2015-10-07	Common Stock	S	3500	$3.0025	Disposed	125938	Direct
2015-10-08	Common Stock	M	4555	$0.44	Acquired	130493	Direct
2015-10-08	Common Stock	S	1500	$2.988	Disposed	128993	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-10-06	Employee Stock Option (right to buy)	$0.44	M	12614	Disposed	2015-12-31	Common Stock (12614)	Direct
2015-10-07	Employee Stock Option (right to buy)	$0.44	M	10764	Disposed	2015-12-31	Common Stock (10764)	Direct
2015-10-08	Employee Stock Option (right to buy)	$0.44	M	4555	Disposed	2015-12-31	Common Stock (4555)	Direct

Footnotes

F1: The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan (the "Plan"), adopted by the Reporting Person on June 14, 2015. Pursuant to the Plan and in compliance with the Issuer's IPO Lock-up Agreements with Credit Suisse Securities (USA) ("CSSU"), the Reporting Person paid the exercise price and CSSU sold shares only to satisfy the tax liability and costs. The balance of the shares will be held until the expiration of the IPO Lock-up Agreements.

F2: This transaction was executed in multiple trades at prices ranging from $3.00 to $3.50. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $2.96 to $3.04. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $2.95 to $3.01. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: The option is fully exercisable as of the date hereof.